OTC Cannabidiol Sleep Study Kicks Off

Koala sleeping

Hemp Gazette wrote an article covering Ananda Hemp’s clinical trail.

“… the race is on to be the first to market to tap into the pent-up demand in Australia for OTC CBD.

Targeting restless sleepers, Southern Cross University researchers have commenced a Phase IIb double blind, randomised, placebo-controlled, multi-site clinical trial funded Australia’s Ecofibre. Ecofibre subsidiary Ananda Hemp’s CBD extract in the form of a low-dose botanical CBD soft gel will be used in the trial and compared to a placebo.”

Read more on their website:

Read the full article